Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
set decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
set decrease » step decrease (Expand Search), we decrease (Expand Search), sizes decrease (Expand Search)
-
1221
-
1222
-
1223
-
1224
-
1225
-
1226
Summary of key questions and follow-up probes used in the phenomenological study.
Published 2025Subjects: -
1227
-
1228
KO of iPLA<sub>2</sub>γ attenuates development of albuminuria in STZ-induced diabetic nephropathy.
Published 2024Subjects: -
1229
-
1230
Control (Ctrl) GECs are more susceptible to injury compared to iPLA<sub>2</sub>γ KO GECs.
Published 2024Subjects: -
1231
-
1232
Podocyte numbers in control and iPLA<sub>2</sub>γ KO mice (WT1-positive cells).
Published 2024Subjects: -
1233
-
1234
-
1235
-
1236
-
1237
Baseline characteristics of mother–infant pairs by child mortality status (N = 11,519).
Published 2025Subjects: -
1238
Child mortality rate per 1,000 person-years during the 18-month follow-up period.
Published 2025Subjects: -
1239
Kaplan–Meier cumulative survival curve for infants exposed and not exposed to HIV.
Published 2025Subjects: -
1240